Home » Topics » Conferences

Conferences
RSS

French group develops new inhibitors of HIV-1 protease dimerization

July 10, 1998

AMD-3100: a potent chemokine CXCR4 antagonist enters clinical testing

July 10, 1998

Anti-HIV peptide T-22 acts as a CXCR4 receptor antagonist

July 10, 1998

Enzo discovery paves the way for antisense therapy of AIDS

July 10, 1998

IL-4 fusion toxin shows potent antitumor activity in murine model of KS

July 10, 1998

New nonfeminizing estrogens with radical-scavenging activity

July 10, 1998

Clinical trial results in RA reported for T-614

July 9, 1998

Mechanism of action of new antiarthritic drug KE-298

July 9, 1998

MX-68: mechanisms underlying antiinflammatory activity

July 9, 1998

AMD-3465, a selective CXCR4 antagonist with potent anti-HIV activity

July 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...